1. Home
  2. HRYU vs MRNS Comparison

HRYU vs MRNS Comparison

Compare HRYU & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRYU
  • MRNS
  • Stock Information
  • Founded
  • HRYU 2018
  • MRNS 2003
  • Country
  • HRYU South Korea
  • MRNS United States
  • Employees
  • HRYU N/A
  • MRNS N/A
  • Industry
  • HRYU Computer Software: Programming Data Processing
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HRYU Technology
  • MRNS Health Care
  • Exchange
  • HRYU Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • HRYU 12.9M
  • MRNS 15.1M
  • IPO Year
  • HRYU 2023
  • MRNS 2014
  • Fundamental
  • Price
  • HRYU $0.29
  • MRNS $0.24
  • Analyst Decision
  • HRYU
  • MRNS Buy
  • Analyst Count
  • HRYU 0
  • MRNS 12
  • Target Price
  • HRYU N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • HRYU 419.0K
  • MRNS 830.0K
  • Earning Date
  • HRYU 11-20-2024
  • MRNS 11-12-2024
  • Dividend Yield
  • HRYU N/A
  • MRNS N/A
  • EPS Growth
  • HRYU N/A
  • MRNS N/A
  • EPS
  • HRYU N/A
  • MRNS N/A
  • Revenue
  • HRYU N/A
  • MRNS $31,466,000.00
  • Revenue This Year
  • HRYU N/A
  • MRNS $15.71
  • Revenue Next Year
  • HRYU N/A
  • MRNS $40.57
  • P/E Ratio
  • HRYU N/A
  • MRNS N/A
  • Revenue Growth
  • HRYU 85.47
  • MRNS 1.63
  • 52 Week Low
  • HRYU $0.17
  • MRNS $0.23
  • 52 Week High
  • HRYU $1.16
  • MRNS $11.26
  • Technical
  • Relative Strength Index (RSI)
  • HRYU 58.37
  • MRNS 25.86
  • Support Level
  • HRYU $0.24
  • MRNS $0.23
  • Resistance Level
  • HRYU $0.30
  • MRNS $0.30
  • Average True Range (ATR)
  • HRYU 0.03
  • MRNS 0.02
  • MACD
  • HRYU 0.00
  • MRNS 0.02
  • Stochastic Oscillator
  • HRYU 67.35
  • MRNS 12.59

About HRYU Hanryu Holdings Inc.

Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: